Gout is one type of arthritis, which is caused by the high levels of uric acid in the blood. The main symptoms of gout are sudden attack of burning pain, swelling in a joint, and stiffness, usually in toe. If it is not treated, over time, it can harm tendons, joints, and other tissues. NSAIDs and urate-lowering agents are preferred treatment options for gout.

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Gout: Disease overview

PART 06: Pipeline portfolio

PART 07: Market landscape

Market overview

Five forces analysis

PART 08: Key buying criteria

PART 09: Market segmentation by drug class

NSAIDs

Corticosteroids

Colchicine

Urate-lowering agents

PART 10: Market segmentation by type of disease

PART 11: Geographical segmentation

Gout therapeutics market in Americas

Gout therapeutics market in EMEA

Gout therapeutics market in APAC

Market overview

PART 12: Market drivers

Introduction of novel urate-lowering agents

Technological advancements in medical imaging

Popularity of off-label and OTC drugs

PART 13: Impact of drivers

PART 14: Market challenges

Low physician and patient awareness

Heavy dependency on generic drugs

Use of CAM for treatment of gout

PART 15: Impact of drivers and challenges

PART 16: Market trends

Focus on regenerative medicines

High growth potential of biologics

Preference for combination therapies

PART 17: Vendor landscape

Competitive scenario

Other prominent vendors

PART 18: Key vendor analysis

AstraZeneca

Horizon Pharma

Takeda Pharmaceuticals

PART 19: Appendix

List of abbreviations

PART 20: Explore Technavio